(LWAY) Lifeway Foods - Overview
Stock: Kefir, Cheese, Yogurt, Butter, Cream
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 40.7% |
| Relative Tail Risk | -26.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -13.32 |
| Character TTM | |
|---|---|
| Beta | 0.369 |
| Beta Downside | 0.454 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.45% |
| CAGR/Max DD | 0.95 |
Description: LWAY Lifeway Foods December 29, 2025
Lifeway Foods, Inc. (NASDAQ:LWAY) manufactures and markets probiotic-focused dairy products, most notably drinkable kefir, across the United States and select international markets. Its portfolio also includes European-style soft cheeses, butter, sour cream, drinkable yogurt, and a children-targeted kefir line called ProBugs, sold under the Lifeway, Fresh Made, GlenOaks Farms, and various private-label brands via a mix of direct sales, brokers, and distributors.
Key performance indicators show the company generated approximately $560 million in revenue for FY 2023, reflecting a year-over-year growth rate of roughly 12 % driven by expanding kefir consumption and a 30 % YoY increase in direct-to-consumer sales. Gross margins have stabilized near 38 %, while the broader probiotic and functional-food segment is expected to grow at a 7 % CAGR through 2028, supported by rising consumer emphasis on gut health and premium-price willingness. However, input cost inflation-particularly for dairy and packaging-remains a material risk that could compress margins if not offset by pricing power.
For a deeper quantitative look, you might explore ValueRay’s detailed LWAY valuation model.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 11.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -17.57 > 1.0 |
| NWC/Revenue: 14.89% < 20% (prev 15.42%; Δ -0.52% < -1%) |
| CFO/TA 0.07 > 3% & CFO 8.10m > Net Income 11.2m |
| Net Debt (-22.6m) to EBITDA (20.7m): -1.10 < 3 |
| Current Ratio: 2.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.4m) vs 12m ago 1.03% < -2% |
| Gross Margin: 27.27% > 18% (prev 0.26%; Δ 2701 % > 0.5%) |
| Asset Turnover: 203.2% > 50% (prev 199.3%; Δ 3.92% > 0%) |
| Interest Coverage Ratio: 284.8 > 6 (EBITDA TTM 20.7m / Interest Expense TTM 59.0k) |
Altman Z'' 9.14
| A: 0.28 (Total Current Assets 53.8m - Total Current Liabilities 23.4m) / Total Assets 109.5m |
| B: 0.79 (Retained Earnings 86.1m / Total Assets 109.5m) |
| C: 0.17 (EBIT TTM 16.8m / Avg Total Assets 100.4m) |
| D: 3.46 (Book Value of Equity 92.6m / Total Liabilities 26.8m) |
| Altman-Z'' Score: 9.14 = AAA |
Beneish M -2.97
| DSRI: 1.12 (Receivables 17.4m/13.9m, Revenue 204.1m/182.0m) |
| GMI: 0.97 (GM 27.27% / 26.41%) |
| AQI: 0.79 (AQ_t 0.17 / AQ_t-1 0.22) |
| SGI: 1.12 (Revenue 204.1m / 182.0m) |
| TATA: 0.03 (NI 11.2m - CFO 8.10m) / TA 109.5m) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of LWAY shares?
Over the past week, the price has changed by -2.59%, over one month by -2.85%, over three months by -12.52% and over the past year by -3.77%.
Is LWAY a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LWAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35 | 63.1% |
| Analysts Target Price | 35 | 63.1% |
| ValueRay Target Price | 28.6 | 33.2% |
LWAY Fundamental Data Overview February 02, 2026
P/S = 1.644
P/B = 4.0536
P/EG = 7.54
Revenue TTM = 204.1m USD
EBIT TTM = 16.8m USD
EBITDA TTM = 20.7m USD
Long Term Debt = 358.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 69.0k USD (from shortTermDebt, last quarter)
Debt = 358.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -22.6m USD (from netDebt column, last quarter)
Enterprise Value = 312.9m USD (335.5m + Debt 358.0k - CCE 23.0m)
Interest Coverage Ratio = 284.8 (Ebit TTM 16.8m / Interest Expense TTM 59.0k)
EV/FCF = -110.7x (Enterprise Value 312.9m / FCF TTM -2.83m)
FCF Yield = -0.90% (FCF TTM -2.83m / Enterprise Value 312.9m)
FCF Margin = -1.38% (FCF TTM -2.83m / Revenue TTM 204.1m)
Net Margin = 5.47% (Net Income TTM 11.2m / Revenue TTM 204.1m)
Gross Margin = 27.27% ((Revenue TTM 204.1m - Cost of Revenue TTM 148.4m) / Revenue TTM)
Gross Margin QoQ = 30.31% (prev 28.57%)
Tobins Q-Ratio = 2.86 (Enterprise Value 312.9m / Total Assets 109.5m)
Interest Expense / Debt = 5.87% (Interest Expense 21.0k / Debt 358.0k)
Taxrate = 30.70% (1.56m / 5.09m)
NOPAT = 11.6m (EBIT 16.8m * (1 - 30.70%))
Current Ratio = 2.30 (Total Current Assets 53.8m / Total Current Liabilities 23.4m)
Debt / Equity = 0.00 (Debt 358.0k / totalStockholderEquity, last quarter 82.8m)
Debt / EBITDA = -1.10 (Net Debt -22.6m / EBITDA 20.7m)
Debt / FCF = 8.01 (negative FCF - burning cash) (Net Debt -22.6m / FCF TTM -2.83m)
Total Stockholder Equity = 76.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.11% (Net Income 11.2m / Total Assets 109.5m)
RoE = 14.51% (Net Income TTM 11.2m / Total Stockholder Equity 76.9m)
RoCE = 21.75% (EBIT 16.8m / Capital Employed (Equity 76.9m + L.T.Debt 358.0k))
RoIC = 15.15% (NOPAT 11.6m / Invested Capital 76.9m)
WACC = 7.28% (E(335.5m)/V(335.8m) * Re(7.28%) + D(358.0k)/V(335.8m) * Rd(5.87%) * (1-Tc(0.31)))
Discount Rate = 7.28% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.81%
Fair Price DCF = unknown (Cash Flow -2.83m)
EPS Correlation: 43.66 | EPS CAGR: 47.26% | SUE: -3.48 | # QB: 0
Revenue Correlation: 96.86 | Revenue CAGR: 17.74% | SUE: 0.84 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.070 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.23 | Chg30d=-0.100 | Revisions Net=-1 | Growth EPS=+19.4% | Growth Revenue=+13.6%